ATLANTA--(BUSINESS WIRE)--Clearside Biomedical, a Georgia-based company developing therapeutics to treat sight threatening diseases through a proprietary ocular microinjection platform, is pleased to announce William (Bill) D. Humphries has joined its board of directors as an independent member.
